




Hearing impairment and incident physician diagnosed dementia: findings from the 
English Longitudinal Study of Ageing. 
 
Hilary Davies1, Dorina Cadar1, Annie Herbert1, Martin Orrell2 and Andrew Steptoe1. 
1 Department of Epidemiology and Public Health, University College London, London, UK 
2 Institute of Mental Health, University of Nottingham, Nottingham, UK 
 
Correspondce should be addressed to Hilary Davies, Department of Epidemiology and Public Health, 
University College London, London, UK. Email: h.davies.12@ucl.ac.uk 
 
Annie Herbert 



















Purpose:  To investigate if hearing-loss is associated with dementia in a representative 
sample of adults aged over 50 years in England.  
Methods:  We analysed data from the English Longitudinal Study of Ageing. Cross-sectional 
associations between both self-reported (n=7,865) and objective hearing measures (n=6,902) 
and dementia were examined using multinomial-logistic regression. Additionally, we 
modelled the longitudinal association between self-reported hearing reported at wave 2 
(2004) and cumulative-physician-diagnosed dementia up to wave 7 (2015) using Cox 
(proportional-hazards) regression. 
Results:  After adjustment for potential confounders, in cross-sectional analysis, participants 
who had either self-reported and objective moderate- and poor-hearing were more likely to 
have a dementia diagnosis compared with individuals who had normal-hearing (self-
reported:OR:1.6, 95% CI:1.1-2.4 and 2.6, 95% CI:1.7-3.9, objective:OR:1.6, 95% CI:1.0-2.8 
and 4.4, 95% CI:1.9-9.9 respectively). Longitudinally, the hazard of developing dementia 
was 1.39 (95% CI:1.0-1.9) and 1.57 (95% CI:1.1-2.0) higher in individuals who reported 
moderate- and poor-hearing respectively.  
Conclusion:  Older adults with hearing-loss are at higher risk of dementia than those with 
normal-hearing. Our findings are consistent with the rationale that correction of hearing-loss 
could help delay the onset of dementia, or that hearing-loss itself could serve as a risk 
indicator for cognitive decline. The public health implications are considerable as over 3-
million UK-adults aged over 50 years currently have hearing-loss. 
 






The global estimate of individuals living with dementia was 46.8 million in 2015, 
with around 800,000 residing in the United Kingdom (UK) and 676,000 living in England 
(1).  The estimated economic cost of dementia in the UK is approximately £23 billion per 
annum, which is predicted to increase threefold by 2040 (1).  Additionally, the overwhelming 
social impact on individuals with dementia and their families has contributed to dementia 
becoming a public health priority (2–4).   
A number of modifiable risk factors for dementia have been identified including 
social interactions, physical activity and type 2 diabetes (5).  There is also evidence that 
hearing loss could be a potential risk factor (6–8).  As with dementia, the risk of hearing loss 
increases with age.  Over 3 million adults aged over 50 years and older in the UK were 
estimated to have hearing loss in 2011, despite the fact that reporting or diagnosing these 
conditions is challenging (9).  The Health Survey for England found that only 26% of 
individuals with moderate or severe objective hearing-loss had previously had a formal 
hearing test, and that 60% of individuals over the age of 55 years who could have improved 
hearing with a hearing aid, had never used one (10).   
Previous longitudinal epidemiological studies conducted in the USA and Wales have 
provided evidence for hearing loss being independently associated with dementia (6-7,11-12).  
Because these studies, however, have either focused on adults over the age of 70 years (11), 
only included men in their analysis (6), not included the use of hearing aids as a confounding 
factor (6,12), had a relatively small sample size (7), or had no objective hearing measure (12).  
We therefore aimed to investigate if both subjective and objective measures of hearing-loss 
were independently associated with dementia using cross-sectional and longitudinal analysis 




We used data from a cohort of men and women, aged over 50 years and older, from 
the English Longitudinal Study of Ageing (ELSA) (13).  ELSA is a panel study which was 
set up in 2002 as a parallel study design to the Health and Retirement Study in the USA (13). 
Face to face interviews and tests have been carried out at two-year intervals (waves 1-7) to 
obtain information regarding socio-economic circumstances, physical and mental health and 







To define dementia, we used a three way assessment protocol as described previously 
by Khondoker et al (14).  The primary criterion was a doctor diagnosis of dementia as 
reported by participants or informants in waves 1-7 (14).  Secondly, carers completed an 
adapted short form Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE) 
for individuals who were not able to respond themselves (14). The carers were asked to 
compare the present functional performance of the participant with 2 years before, instead of 
the 10 year interval in the standard measure (15).  Consistent with previous work, we defined 
those with a cut-off of 3.5 with dementia as the IQCODE has both a high specificity (0.84) 
and sensitivity (0.82) at this cut-off (14,16).  Finally, we also defined dementia as such if 
individuals were receiving prescriptions for anticholinesterase inhibitors, NMDA receptor 
antagonists or other relevant medication (galantamine, rivastigmine, memantine, donepezil, 
or tacrine (17,18).  Many people with dementia do not have a formal diagnosis (19).  These 
analyses should therefore be regarded as a measure of physician-diagnosed dementia and not 
complete incident dementia. 
 
Exposure measures 
Self-reported hearing  
Participants were asked to rate their hearing from 1-5 (1=excellent, 5=poor) in waves 
1-7 (20).  If an individual had a hearing aid, they were asked to rate their hearing based on 
when they were using their hearing aid (20).  We used self-reported hearing at wave 2 
(longitudinal analysis) and wave 7 (cross-sectional analysis).  There were originally 5 self-
reported hearing groups (excellent, very good, good, fair and poor hearing) and we combined 
fair and poor, and excellent and very good, to create three categories for analysis (normal, 
moderate difficulties and poor hearing) (10,20). 
 
Objective hearing test  
A hearing screening device, the HearCheck Screener™ manufactured by Siemens, 
was used to obtain objective hearing scores for participants at wave 7.  This device has been 
validated and previously used in the Health Survey for England in 2014 (10).  Hearing loss 
was measured using the Decibel Hearing Level (dbHL) which is the increase of decibels in 
order for a person to hear a sound at a certain frequency for at least 50% of the time (10).  
The test involves the presentation of six increasing volumes of  sounds at different frequency 
levels and participants indicate which tones they can hear (10,21).  Both ears were tested in a 
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quiet environment and hearing aids were removed before the test (10).  The HearCheck test 
was not carried out with people who had either a cochlear implant or ear infection (10).  
Individuals were classified with hearing loss if they could only hear mid-frequency sounds at 
dbHL of 20 and high frequency sounds at 35 dbHL.  Responses were originally categorised 
into 4 groups (good hearing, moderate loss, severe loss and profound loss).  For the current 
study, the lower two (severe and profound loss) were combined, resulting in three groups 
(normal, moderate difficulties and poor hearing)  
 
Other independent variables 
We classified age into four categories (50-59, 60-69, 60-79, and 80 years of age and 
over).  Economic status was defined using quintiles of non-pension wealth (1=low, 5=high) 
as calculated by Institute for Fiscal Studies (13).  We divided participants’ highest 
educational qualifications into three groups; no formal qualification, intermediate and higher 
education.  Ethnicity was divided into White and non-White.  Smoking was categorised into 
three groups; never smoked, ex-smoker and current smoker.  The following variables were 
binary: use of hearing aid, diabetes, hypertension, and history of stroke (22).   
 
Statistical analysis 
The socio-demographic and clinical risk profiles were summarised by self-reported 
(waves 2 and 7) and objective hearing categories (wave 7).  Chi-square tests were performed 
to ascertain if there were significant differences in the distribution of socio-demographic and 
clinical categories between hearing groups.  For the cross-sectional analyses of self-reported 
and objective hearing impairments, odds ratios and 95% confidence intervals of diagnosed 
dementia at wave 7 were calculated, with normal hearing as the reference group.  Separate 
analyses were carried out on self-reported and objective hearing impairment.  We decided a 
priori on the basis of the existing literature that age, gender, ethnicity, wealth, education and 
hearing aid use were possible confounders (7,11,23).  Additionally, we adjusted for the 
following cardiovascular risk factors; smoking status, diabetes, hypertension and stroke.  We 
used a forward stepwise approach and performed likelihood ratio tests and Akaike 
information criterion to select the model of best fit (24,25).  
We used Cox proportional hazards regression to model the association between self-
reported hearing (wave 2) and cumulative diagnosed dementia (wave 3 to 7 from July 2005 to 
June 2015).  We applied inverse probability weighting to control for non-response bias 
(22,26).  Individuals who had been diagnosed with dementia in wave 2 were excluded.  The 
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time to dementia was measured in years from the beginning of wave 2.  Date of dementia 
diagnosis was used if known; if not known, we used the midpoint date between waves of data 
collection.  We censored individuals who were known to have died or left the study.  
Mortality data for ELSA were available up to February 2013.  If an individual dropped out of 
the study between waves, we used the last interview date for the censor date.  We used the 
Schoenfeld residual test to test the proportional-hazards assumption of the models (27).   
 
Sensitivity analysis 
In order to examine if the self-report and objective measures had independent effects 
on risk of dementia, we included both measures in one model.  Additionally, we excluded 
individuals who wore hearing aids in the sensitivity analysis because the self-report measure 
was based on hearing aid use whereas the objective measure was not.   
All data were analysed using STATA Statistical Software (version 14) (Stata Corp LP, 




In total, 95% (7,865/8,253) of the participants in wave 7 rated their hearing, with a 
fifth (23.1%, n=1,771) reporting poor and a third (34.7%, n=2,669) moderate hearing 
difficulties.  Self-reported hearing difficulties were associated with greater age, male gender, 
lower wealth and education, hearing aid use, a history of stroke and a co-morbidity of either 
diabetes or hypertension (Error! Reference source not found.).   
Insert Table 1 
Some 84% (6,902/8,253) of the participants had a HearCheck test in wave 7 (Table 
2).  Compared with the self-reported hearing categories, fewer individuals were categorised 
into the poor objective hearing group (5.2% vs 23.1%), but a similar proportion (33.5% vs 
34.7%) were in the moderate hearing group.  Objective hearing difficulties were associated 
with a similar set of demographic and clinical factors as in the case of self-reported hearing 
(Table 2).   
Insert Table 2 
Dementia was associated with worse self-reported and objective hearing (Table 3).  
After adjustment for confounders, participants in the moderate and poor self-reported hearing 
groups were 1.6 (95% CI: 1.05-2.37) and 2.6 (95% CI: 1.74-3.93) times more likely to have a 
dementia diagnosis compared with individuals who had normal hearing.  Similarly, those in 
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the moderate and poor hearing groups for the HearCheck test were 1.6 (95% CI: 0.93-2.84) 
and 4.4 (95% CI: 1.94-9.91) times more likely to have a diagnosis of dementia.  Increased 
age, hypertension and previous stroke were risk factors for dementia diagnosis, whereas 
greater wealth, intermediate and higher education and using a hearing aid seemed to have 
protective effects. (Table 3) 
Insert Table 3 
Longitudinal analyses 
Of the 8,780 core members in wave 2, a fifth (22%, n=1,933) reported poor hearing 
and a third (31.6%, n=2,774) moderate hearing difficulties.  Self-reported hearing difficulties 
was associated with greater age, male-gender, lower wealth and education, hearing aid use, a 
co-morbidity of hypertension and a history of a stroke (Table 4).   
Insert Table 4 
There were 269 incident cases of diagnosed dementia between wave 2 and the end of 
wave 7 (June 2015).  During the mean follow-up period of 11 years, individuals in the 
moderate and poor hearing groups were at increased risk of developing dementia compared 
with the normal hearing group, with hazard ratios of 1.39 (95% CI: 1.01-1.92) and 1.57 
(1.12-2.02) respectively.  Both increasing age and the presence of diabetes also emerged as 
significant independent risk factors. (Table 5) 
Insert table 5 
 
Sensitivity analysis 
There was a fair agreement between the objective and self-reported hearing measures 
(κ=0.262, 95% CI 0.257-0.269).  The association between objective hearing and physician 
diagnosed dementia remained significant for the poor hearing group when including self-
reported hearing in the model.  In contrast the association between self-reported hearing 
difficulties weakened and became non-insignificant. (Supplementary Table 1).  The 
associations did not change when we excluded individuals who used a hearing aid. 
 
Discussion 
Our study supports the evidence that both moderate and poor objective and self-
reported hearing are both associated with physician-diagnosed dementia in a representative 
sample of English older adults (mean age 70 ±9.5 years) cross-sectionally.  Longitudinal 
analysis over an 11 year period showed that the incidence was 39% and 57% higher in 
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individuals with moderate and poor self-reported hearing compared with individuals with 
normal hearing after adjusting for multiple covariates.   
 
Comparison with other studies 
The Health and Retirement Study (HRS) which has a similar profile to ELSA also 
examined self-reported hearing and dementia cross-sectionally and found that 44% of 
participants who reported fair to poor hearing had probable dementia (28).  The HRS analysis 
focused on the last two years of life rather than a more prolonged period, and their definition 
of probable dementia was based on an algorithmic analysis of cognitive function rather than 
physician diagnoses (28,29). 
Our findings build on previous longitudinal studies conducted in the USA and Wales, 
which found increased hazard ratios of developing dementia in individuals with moderate and 
severe hearing loss (6-7,12,22).  Lin et al prospectively analysed 639 older adults (>65 years) 
from the Baltimore Longitudinal Study of Aging over 11.9 years (7). They found that not 
only was objective hearing loss independently associated with incident dementia, but that risk 
also increased log-linearly with the severity of hearing loss (mild hearing loss HR: 1.89, 95% 
CI: 1.00-3.58, moderate hearing loss HR: 3.00, 95% CI:1.43-6.30 and severe hearing loss, 
HR: 4.94 , 95% CI:1.09-22.40) (7).  The confidence interval for the severe hearing loss 
category was large, probably because of the small number of cases in that category (n=6).  
Deal et al tracked older adults (n=1,889, 70-79 years) from the Health, Ageing and Body 
Composition study for 9 years and the results suggested that individuals with moderate/severe 
objective hearing impairment had a higher rate of developing dementia than those whose 
hearing was normal (HR: 1.55, 95% CI: 1.10-2.19).  Older men from the Caerphilly Study in 
Wales (n=1,057) were followed for 17 years and results showed an association between 
objective auditory threshold and dementia (OR: 2.67, 95% CI: 1.38-5.18).  Unlike the other 
previous studies, they only included males in their analysis (6).  Finally, the Cache County 
Study on Memory, Health, and Aging in the USA (n=4,545) followed older adults (> 65 
years) for 13 years and also found that hearing loss was an independent risk factor for 
developing dementia (12).  However, the identification of hearing loss was questionable since 
it was based on interviewer ratings that were not a mandatory part of the assessment protocol 
The previous studies of objective hearing loss used a Pure Tone Audiometry (PTA) 
test, whereas we used self-reported hearing measures in our longitudinal analyses (6-7,11).  
We did however find a significant positive association between the self-reported and 
objective HearCheck test measure in wave 7.  Additionally PTA and HearCheck tests are 
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comparable with similar sensitivities (89% compared with 94%) and specificities (87% and 
82%) (30). However, when self-reported and objective measures were entered into the same 
models competitively, associations between objective hearing loss and dementia were more 
robust. 
 
Strengths and limitations 
A unique strength of using ELSA is that it involves a large national sample of resident 
English men and women aged over 50 years and older.  The dataset includes repeated 
measures of chronic conditions and therefore we were able to capture cumulative physician-
diagnosed dementia cases and analyse time to dementia diagnosis.  The dataset also had 
measures of both self-report and objective hearing measures at wave 7 which we were able to 
compare in the presence of potential other covariate measures.  
There are also several limitations to these analyses.  Firstly, in comparison with 
population estimates, there were fewer dementia cases in this study (31,32).  This is primarily 
due to the identification of dementia on the basis of physician diagnoses, since it is thought 
that only around half of people living with dementia, have had a formal diagnosis (33).  We 
therefore also included dementia cases based on IQCODE above 3.5 (15,29,34).  Attrition 
bias is also relevant (27), though we allowed for this by using probability weights for non-
responders (22,26).   
Secondly, only self-reported hearing measures were available in ELSA for 
longitudinal analysis, where objective measures would be desirable.  The comparison 
between subjective and objective measures of hearing loss was also challenging, as only the 
self-reported hearing was based on hearing aid use.  However we found that the two measures 
had a significant positive association.  Additionally, we included the use of a hearing aid as a 
confounder in our analysis.   
 
Possible causal mechanisms 
There are three possible mechanisms supporting hearing-loss as a cause of dementia; 
increased cognitive burden, changes in brain structure and function and increased social 
isolation.  Firstly, increased cognitive burden or the “effortfulness hypothesis” was 
demonstrated by both McCoy et al and Tun et al in older adults (66-81 years) (34-35).  
Although the numbers of older adults with hearing impairment were relatively small (n=12 
and n=24), their findings suggested that older individuals with hearing-loss had both poorer 
recall and reduced secondary task performance (35,36).  Sound signals become more 
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distorted in individuals with hearing-loss, especially in the high frequency range, leading to 
an increased effort in perceiving sound (35,36).  The extra cognitive load on those with 
hearing-loss could be at the expense of encoding and processing speech into memory (35,36).   
Secondly, decreased sensory input and processing may lead to changes in brain 
structure and function (6–8).  Evidence from cross-sectional studies suggests that hearing 
impairment is associated with a reduction in the cortical volume of the primary auditory 
cortex in the temporal lobe and variable white matter fibres (37).  The evidence was 
strengthened by neuroimaging data from participants enrolled in the neuroimaging sub-study 
of the Baltimore Longitudinal Study for Ageing, showing that hearing impairment in older 
adults was associated with an increased rate of decline of the whole brain volume, 
particularly in the right temporal lobe which is responsible for processing of speech (38).  
The majority of individuals (n=126, 58-86 years old) with hearing impairment were in the 
mild hearing category.  
Finally, decreased interaction and intellectual stimulation has been associated with 
dementia in prospective studies (38-39).  Social gatherings may become more challenging for 
individuals with hearing impairment as they use more cognitive resources to process speech 
which may increase withdrawal from social activities.  Wang et al examined Swedish older 
adults prospectively (n=776, >75 years old), and the results suggested that individuals who 
participated less in social, mental or physical activity had a higher risk of developing 
dementia (39).  Furthermore, cross-sectional and prospective studies have shown an 
independent association between hearing loss and social isolation (41). Social isolation may 
therefore be a mediator on the causal pathway of dementia through which hearing impairment 
might act (41). 
 
Clinical implications 
Is hearing-loss an indicator of early stages of dementia and a preventable risk factor, 
or is dementia an indicator of hearing-loss?  There is an opposing argument of the direction 
of association between hearing and dementia, however either pathway could have major 
public health implications.   
In the UK, approximately four million people with hearing impairment delay seeking 
medical help (42).  Unlike eye tests, individuals seem to be more reluctant to have hearing 
tests possibly due to the stigma associated with hearing-loss, which could be reduced by a 
screening programme (42).  One study of hearing screening for older adults showed a 
positive benefit to cost ratio (43).  Consequently, the Department of Health have developed 
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an action plan on hearing which includes awareness, early detection and treatment for hearing 
loss (44).   
Hearing aids could help with the treatment of hearing loss and possibly decrease 
social isolation, although they need to be acceptable and effective.  The quality of hearing 
aids seems to have improved and 70% of older adults reported being fairly satisfied with their 
hearing aid in the Health Survey for England (10).  Individuals who were tested at a younger 
age, benefitted more from their hearing aid as they had more time to adapt (42).  Together 
with detection and treatment, hearing loss could also be an early indicator for testing for 
cognitive decline and dementia.  
 
Conclusion 
In conclusion, our study supports the hypothesis that older adults with hearing-loss 
have a higher rate of developing dementia.  We also found that hearing aid use had a 
protective effect cross-sectionally.  Our findings suggest that treatment of hearing loss with 
hearing aids could help delay the onset of dementia.  The public health implications are 
substantial as over 3 million UK adults aged over 50 years and older currently have hearing-
loss.  Further studies are still needed to confirm the possible biological and social 
mechanisms involved and a large prospective study to examine treatment of hearing loss. 
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Table 1: Descriptive statistics of dementia and self-reported hearing test (Wave 7)  
 Self-reported hearing 
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Table 2: Descriptive statistics of dementia and objective hearing test (Wave 7)  
 Objective hearing screening test 







































































































































































































































































































































Model 1   Model 2   Objective 
hear-test  
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Table 4. Descriptive statistics of dementia and self-reported hearing (Wave 2)  
 Self-reported hearing 
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Table.5. Hazard ratios of self-reported hearing at wave 2 and cumulative dementia (Waves 3-7) 
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